- SARMs, although selective, can suppress the hormonal axis and require a well-planned post-cycle recovery strategy.
- Skipping post cycle therapy (PCT) after a SARMs cycle can lead to muscle mass loss, hormonal dysfunction, and prolonged adverse effects.
- The severity of suppression varies by compound, dosage, and cycle duration, making monitoring through laboratory analysis indispensable.
- At Alba Pharma, we offer laboratory-grade products with fast and discreet shipping to Mexico, the United States, and Brazil.
SARMs Cycle and Post-Cycle Guide: Why Ignoring PCT Is a Costly Mistake
There is a widespread belief that Selective Androgen Receptor Modulators (SARMs) do not require post-cycle therapy due to their selective nature. In our professional opinion, this idea is one of the most detrimental errors in contemporary sports pharmacology. This SARMs cycle and post-cycle guide addresses, from a technical perspective, why hormonal recovery is not optional, but essential to preserve results and protect user health.
Suppression of the Hypothalamic-Pituitary-Gonadal (HPG) Axis
SARMs-induced suppression mechanism
Although SARMs were designed to selectively activate androgen receptors in muscle and bone tissue, their systemic action generates negative feedback on the HPG axis. The body detects exogenous androgenic signaling and reduces the endogenous production of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which decreases natural testosterone synthesis.
Compounds such as LGD-4033 (Ligandrol) and RAD-140 (Testolone) have demonstrated significant levels of hormonal suppression in scientific literature, even at moderate doses and in 8-week cycles.
Consequences of omitting recovery
- Accelerated loss of muscle mass gained during the cycle.
- Decreased libido and possible erectile dysfunction.
- Chronic fatigue, mood alterations, and brain fog.
- Prolonged hormonal recovery that can extend for months without intervention.
Post Cycle Therapy SARMs: Determining Variables
The necessity and intensity of post cycle therapy SARMs depend on multiple factors that must be evaluated individually with professional support:
| Variable | Impact on suppression |
|---|---|
| Type of SARM used | LGD-4033 and RAD-140 tend to suppress more than Ostarine (MK-2866). |
| Cycle duration | Cycles exceeding 8 weeks significantly increase suppression. |
| Dosage used | High doses generate greater negative feedback on the HPG axis. |
| Stacking compounds | Combining multiple SARMs amplifies the degree of hormonal suppression. |
For this reason, we consider performing hormonal blood work (total testosterone, LH, FSH, and estradiol) before, during, and after any cycle to be essential.
“At Alba Pharma, we maintain that a responsible cycle does not end with the last dose of the compound; it ends when the user’s hormonal values have returned to their baseline levels, verified through laboratory analysis.” — Editorial team of alba-pharma.com
Conclusion: PCT Is Not Optional, It Is Part of the Cycle
As we have outlined in this SARMs cycle and post-cycle guide, the selectivity of these compounds does not exempt them from causing clinically relevant hormonal suppression. Planning an appropriate post cycle therapy SARMs is as important as designing the cycle itself. Omitting it is equivalent to compromising both physical results and general well-being.
All pharmacological decisions must be made under the supervision of a qualified health professional. Alba Pharma does not provide medical advice, diagnoses, or personalized protocols.
If you are looking for high-purity, laboratory-grade SARMs and post-cycle support compounds, at Alba Pharma we have guaranteed stock, 100% discreet packaging, and fast shipping to Mexico, the United States, and Brazil. Explore our catalog and make informed decisions backed by premium quality products.
